Stephen Rinderknecht

Summary

Affiliation: Iowa Health
Country: USA

Publications

  1. pmc The safety profile of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)
    Stephen Rinderknecht
    Iowa Health Physicians, Waukee, IA, USA
    Hum Vaccin Immunother 8:304-11. 2012
  2. doi Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with measles-mumps-rubella and varicella vaccines in children less than 2 years of age
    Stephen Rinderknecht
    Iowa Health Physicians, Waukee, IA, USA
    Pediatr Infect Dis J 30:e179-85. 2011

Collaborators

Detail Information

Publications2

  1. pmc The safety profile of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)
    Stephen Rinderknecht
    Iowa Health Physicians, Waukee, IA, USA
    Hum Vaccin Immunother 8:304-11. 2012
    ..These studies are registered at www.clinicaltrials.gov NCT00345579 (primary vaccination study), NCT00345683 (fourth dose vaccination study) and NCT00289783 (primary and fourth dose vaccination studies)...
  2. doi Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with measles-mumps-rubella and varicella vaccines in children less than 2 years of age
    Stephen Rinderknecht
    Iowa Health Physicians, Waukee, IA, USA
    Pediatr Infect Dis J 30:e179-85. 2011
    ..We assessed the immunogenicity and safety of an inactivated hepatitis A virus vaccine when coadministered with measles-mumps-rubella (MMR) and varicella vaccines in children less than 2 years of age...